首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

全球光學基因組圖譜市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1421052

全球光學基因組圖譜市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Optical Genome Mapping Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球光學基因組圖譜市場需求預計將從 2023 年的 119.07 萬美元達到 2032 年近 1267.1 百萬美元的市場規模，2024-2032 年研究期間複合CAGR為 30.05%。

光學基因組作圖是一種基因組技術，可提供個體整個基因組的高解析度圖譜。與讀取核苷酸鹼基序列的傳統 DNA 定序方法不同，光學基因組作圖涉及長 DNA 分子的直接可視化和分析。該技術利用先進的成像技術（例如螢光顯微鏡）來捕捉拉伸和標記 DNA 鏈的詳細圖像。

市場動態

在多種因素的推動下，光學基因組圖譜市場正在經歷顯著成長。這項技術因其分析基因組結構變異的能力而脫穎而出，提供高解析度圖譜來補充傳統 DNA 定序。人們對了解結構變異在遺傳性疾病和疾病中的作用的興趣日益濃厚，推動了對光學基因組作圖的需求。其在臨床診斷中的應用，特別是在癌症研究和遺傳易感性識別中的應用，有助於其在醫療保健領域的採用。影像技術的進步提高了光學基因組作圖的可靠性，使其對廣泛的基因組學應用更具吸引力。基因組學研究資金的增加、政府舉措以及基因組計畫的激增進一步推動了這項技術的開發和採用。市場的擴張以及光學基因組圖譜與更廣泛的基因組學計劃的整合受到技術開發商、研究機構和醫療保健組織之間的合作和夥伴關係的顯著影響。該技術在基因組研究中的多功能性和互補作用使其成為尋求全面了解基因組結構的研究人員和臨床醫生的寶貴工具。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球光學基因組圖譜市場的每個細分市場進行了包容性評估。光學基因組圖譜產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

光學基因組圖譜市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

儀器
耗材及試劑
軟體
服務

按應用

結構變異檢測
基因組組裝
微生物菌株分型
其他

按最終用戶

生物技術和製藥公司
臨床實驗室
學術研究機構
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲光學基因組圖譜市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。光學基因組圖譜市場的主要參與者包括 Bionano Genomics、Nucleome Informatics Private Limited、Praxis Genomics, LLC、SourceBio International Limited (Source BioScience)、MedGenome、INRAE (法國植物性因組資源中心 (CNRGV))、PerkinElmer (PerkinElmer Genomics) ， Genohub Inc.，Hofkens 實驗室，塞爾巴。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：光學基因組圖譜公司的競爭格局

光學基因組圖譜市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Bionano Genomics

公司簡介
公司收入
產品
最近的發展

Nucleome Informatics Private Limited

公司簡介
公司收入
產品
最近的發展

Praxis Genomics LLC

公司簡介
公司收入
產品
最近的發展

SourceBio International Limited (Source BioScience)

公司簡介
公司收入
產品
最近的發展

MedGenome

公司簡介
公司收入
產品
最近的發展

INRAE (French Plant Genomic Resources Center (CNRGV))

公司簡介
公司收入
產品
最近的發展

PerkinElmer (PerkinElmer Genomics)

公司簡介
公司收入
產品
最近的發展

Genohub Inc.

公司簡介
公司收入
產品
最近的發展

Hofkens Lab

公司簡介
公司收入
產品
最近的發展

Cerba

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113361

The global demand for Optical Genome Mapping Market is presumed to reach the market size of nearly USD 1267.1 MN by 2032 from USD 119.07 MN in 2023 with a CAGR of 30.05% under the study period 2024 - 2032.

Optical genome mapping is a genomic technology that provides a high-resolution map of an individual's entire genome. Unlike traditional DNA sequencing methods, which read the sequence of nucleotide bases, optical genome mapping involves the direct visualization and analysis of long DNA molecules. This technique utilizes advanced imaging technologies, such as fluorescence microscopy, to capture detailed images of stretched and labeled DNA strands.

MARKET DYNAMICS

The Optical genome mapping market is experiencing significant growth driven by various factors. This technology stands out for its ability to analyze structural variations in the genome, offering a high-resolution map that complements traditional DNA sequencing. The rising interest in understanding the role of structural variations in genetic disorders and diseases propels the demand for Optical genome mapping. Its applications in clinical diagnostics, especially in cancer research and genetic predisposition identification, contribute to its adoption in the healthcare sector. Advancements in imaging technologies enhance the reliability of optical genome mapping, making it more attractive for a broad range of genomics applications. Increased funding for genomics research, government initiatives, and a surge in genomic projects further boost the development and adoption of this technology. The expansion of the market and the integration of optical genome mapping into broader genomics initiatives are significantly influenced by collaborations and partnerships among technology developers, research institutions, and healthcare organizations. The technology's versatility and complementary role in genomic studies position it as a valuable tool for researchers and clinicians seeking a comprehensive understanding of genomic architecture.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of optical genome mapping. The growth and trends of optical genome mapping industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the optical genome mapping market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Consumables And Reagents
Software
Services

By Application

Structural Variant Detection
Genome Assembly
Microbial Strain Typing
Others

By End-User

Biotechnology And Pharmaceutical Companies
Clinical Laboratories
Academic Research Institutes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Optical Genome Mapping market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Optical Genome Mapping market include Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, Cerba. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . OPTICAL GENOME MAPPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Consumables and Reagents Historic and Forecast Sales by Regions
5.6 Software Historic and Forecast Sales by Regions
5.7 Services Historic and Forecast Sales by Regions

6 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Structural Variant Detection Historic and Forecast Sales by Regions
6.5 Genome Assembly Historic and Forecast Sales by Regions
6.6 Microbial Strain Typing Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Biotechnology and Pharmaceutical Companies Historic and Forecast Sales by Regions
7.5 Clinical Laboratories Historic and Forecast Sales by Regions
7.6 Academic research institutes Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL OPTICAL GENOME MAPPING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE OPTICAL GENOME MAPPING COMPANIES

9.1. Optical Genome Mapping Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF OPTICAL GENOME MAPPING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Bionano Genomics
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Nucleome Informatics Private Limited
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Praxis Genomics LLC
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. SourceBio International Limited (Source BioScience)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. MedGenome
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. INRAE (French Plant Genomic Resources Center (CNRGV))
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. PerkinElmer (PerkinElmer Genomics)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Genohub Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Hofkens Lab
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Cerba
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments